Kent Oncology Centre, Maidstone Hospital

Maidstone, Kent ME16 9QQ

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, HER-2 Positive Breast Cancer, HER2-Positive Primary Breast Cancer, Malignant Pleural Mesothelioma, Metastatic Neoplasm, Prostate Cancer, Residual Invasive Breast Cancer

Studies at this site

• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed — Completed
• Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer — Completed